MedTrace Logo

Bevacizumab and Retinal Vascular Occlusions

NCT00347711 · Status: WITHDRAWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2024-06-03

No results posted yet for this study

Summary

To evaluate the effects of Intravitreal Bevacizumab in macular edema in retinal vascular occlusion.

Conditions

  • Edema Macular
  • Vascular Occlusion

Interventions

DRUG

Intravitreal injection

Sponsors & Collaborators

  • Asociación para Evitar la Ceguera en México

    lead OTHER

Principal Investigators

  • Griselda Alvarez, Fellow · Asociación para Evitar la Ceguera en México

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-06-30
Primary Completion
2006-06-30
Completion
2006-06-30

Countries

  • Mexico

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00347711 on ClinicalTrials.gov